Cargando…

Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus

Feline infectious peritonitis virus (FIP virus: FIPV) causes a fatal disease in wild and domestic cats. The development of an FIP-preventive vaccine requires an antigen that does not induce antibody-dependent enhancement, and T helper (Th)1 activity plays an important role in protect against FIPV in...

Descripción completa

Detalles Bibliográficos
Autores principales: Takano, Tomomi, Morioka, Hiroyuki, Gomi, Kohji, Tomizawa, Keisuke, Doki, Tomoyoshi, Hohdatsu, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115422/
https://www.ncbi.nlm.nih.gov/pubmed/24530149
http://dx.doi.org/10.1016/j.vaccine.2014.01.074
_version_ 1783514094539636736
author Takano, Tomomi
Morioka, Hiroyuki
Gomi, Kohji
Tomizawa, Keisuke
Doki, Tomoyoshi
Hohdatsu, Tsutomu
author_facet Takano, Tomomi
Morioka, Hiroyuki
Gomi, Kohji
Tomizawa, Keisuke
Doki, Tomoyoshi
Hohdatsu, Tsutomu
author_sort Takano, Tomomi
collection PubMed
description Feline infectious peritonitis virus (FIP virus: FIPV) causes a fatal disease in wild and domestic cats. The development of an FIP-preventive vaccine requires an antigen that does not induce antibody-dependent enhancement, and T helper (Th)1 activity plays an important role in protect against FIPV infection. In the present study, we identified synthetic peptides including Th1 and a linear immunodominant antibody-binding epitope in the S1 domain and M protein of FIPV. We also identified peptides that strongly induce Th1 activity from those derived from the structural proteins (S, M, and N proteins) of FIPV based on this and previous studies (Satoh et al. [19]). No Th1 epitope-containing peptide was identified in the peptides derived from the S1 domain of type I FIPV. In contrast, 7 Th1 epitope-containing peptides were identified in the S1 domain of type II FIPV, and no linear immunodominant antibody-binding epitope was contained in any of these peptides. Eleven Th1 epitope-containing peptides common to each serotype were identified in the M protein-derived peptides, and 2 peptides (M-11 and M-12) contained the linear immunodominant antibody-binding epitope. Of the peptides derived from the S, M, and N proteins of FIPV, those that induced significantly stronger Th1 activity than that of the FIPV antigen were rescreened, and 4 peptides were identified. When 3 of these peptides (M-9, I-S2-15, and II-S1-24) were selected and administered with CpG-ODNs to SPF cats, M-9 and II-S1-24 induced Th1 activity. Our results may provide important information for the development of a peptide-based vaccine against FIPV infection.
format Online
Article
Text
id pubmed-7115422
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71154222020-04-02 Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus Takano, Tomomi Morioka, Hiroyuki Gomi, Kohji Tomizawa, Keisuke Doki, Tomoyoshi Hohdatsu, Tsutomu Vaccine Article Feline infectious peritonitis virus (FIP virus: FIPV) causes a fatal disease in wild and domestic cats. The development of an FIP-preventive vaccine requires an antigen that does not induce antibody-dependent enhancement, and T helper (Th)1 activity plays an important role in protect against FIPV infection. In the present study, we identified synthetic peptides including Th1 and a linear immunodominant antibody-binding epitope in the S1 domain and M protein of FIPV. We also identified peptides that strongly induce Th1 activity from those derived from the structural proteins (S, M, and N proteins) of FIPV based on this and previous studies (Satoh et al. [19]). No Th1 epitope-containing peptide was identified in the peptides derived from the S1 domain of type I FIPV. In contrast, 7 Th1 epitope-containing peptides were identified in the S1 domain of type II FIPV, and no linear immunodominant antibody-binding epitope was contained in any of these peptides. Eleven Th1 epitope-containing peptides common to each serotype were identified in the M protein-derived peptides, and 2 peptides (M-11 and M-12) contained the linear immunodominant antibody-binding epitope. Of the peptides derived from the S, M, and N proteins of FIPV, those that induced significantly stronger Th1 activity than that of the FIPV antigen were rescreened, and 4 peptides were identified. When 3 of these peptides (M-9, I-S2-15, and II-S1-24) were selected and administered with CpG-ODNs to SPF cats, M-9 and II-S1-24 induced Th1 activity. Our results may provide important information for the development of a peptide-based vaccine against FIPV infection. Elsevier Ltd. 2014-04-01 2014-02-11 /pmc/articles/PMC7115422/ /pubmed/24530149 http://dx.doi.org/10.1016/j.vaccine.2014.01.074 Text en Copyright © 2014 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Takano, Tomomi
Morioka, Hiroyuki
Gomi, Kohji
Tomizawa, Keisuke
Doki, Tomoyoshi
Hohdatsu, Tsutomu
Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
title Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
title_full Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
title_fullStr Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
title_full_unstemmed Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
title_short Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
title_sort screening and identification of t helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115422/
https://www.ncbi.nlm.nih.gov/pubmed/24530149
http://dx.doi.org/10.1016/j.vaccine.2014.01.074
work_keys_str_mv AT takanotomomi screeningandidentificationofthelper1andlinearimmunodominantantibodybindingepitopesinspike1domainandmembraneproteinoffelineinfectiousperitonitisvirus
AT moriokahiroyuki screeningandidentificationofthelper1andlinearimmunodominantantibodybindingepitopesinspike1domainandmembraneproteinoffelineinfectiousperitonitisvirus
AT gomikohji screeningandidentificationofthelper1andlinearimmunodominantantibodybindingepitopesinspike1domainandmembraneproteinoffelineinfectiousperitonitisvirus
AT tomizawakeisuke screeningandidentificationofthelper1andlinearimmunodominantantibodybindingepitopesinspike1domainandmembraneproteinoffelineinfectiousperitonitisvirus
AT dokitomoyoshi screeningandidentificationofthelper1andlinearimmunodominantantibodybindingepitopesinspike1domainandmembraneproteinoffelineinfectiousperitonitisvirus
AT hohdatsutsutomu screeningandidentificationofthelper1andlinearimmunodominantantibodybindingepitopesinspike1domainandmembraneproteinoffelineinfectiousperitonitisvirus